Success Story: Our Team Helped an Assistant Professor Secure an NIW Success Without Receiving Any RFE

 

Client’s Testimonial:

“I am sincerely grateful for your support in securing the approval of my NIW petition. I truly appreciate your guidance throughout the process.”


On February 21st, 2025, we received another EB-2 NIW (National Interest Waiver) approval for an Assistant Professor in the Field of Microbiology (Approval Notice).


General Field: Microbiology

Position at the Time of Case Filing: Assistant Professor

Approval Notice Date: February 21st, 2025

Processing Time: 15 months, 14 days


Case Summary:           

We are pleased to share the approval of an I-140 National Interest Waiver (NIW) petition for a highly accomplished Ph.D. holder in microbiology. The petition was approved in February 2025, recognizing the petitioner’s impactful contributions to biotechnology and drug discovery through microbial research in extreme environments.

Advancing Industrial Innovation Through Microbial Diversity Research

The petitioner’s proposed endeavor focuses on exploring microbial diversity and the production of bioactive compounds in harsh ecological conditions such as high salinity, extreme pH, or elevated temperatures. This line of work supports the identification of new antibiotics and industrial enzymes - two areas of critical national importance due to increasing antibiotic resistance and the growing need for sustainable, biologically based industrial processes. His investigations into extremophiles and their metabolite production have helped advance the development of bioactive agents and catalyzed innovation in natural product biosynthesis.

Currently working in academic research, the petitioner continues to isolate, analyze, and characterize novel microbial strains to develop innovative biotechnological solutions with applications in medicine, agriculture, and environmental engineering.

Recognized Expertise and Global Research Impact

The petition was supported by a strong record of scholarly output and evidence of the petitioner’s influence across the scientific community:

  • 52 peer-reviewed journal articles;
  • 1 first-authored conference article, 5 abstracts, and 2 book chapters;
  • A total of 2,352 citations to date, as indexed by Google Scholar;
  • At least 7 completed peer reviews for scientific journals.
His research findings have been widely cited in international studies on antimicrobial screening, novel enzyme production, and microbial genomic profiling, confirming the foundational value of his work across multiple industries.

Supported by Competitive Research Funding

The petitioner’s research has also been backed by major grants from national organizations, including the Higher Education Commission of Pakistan, further validating the scientific importance and institutional confidence in his research direction.

Endorsements from Leading Experts

The petition included two letters of recommendation from established microbiologists. These endorsements emphasized the originality, reliability, and future promise of the petitioner’s work in advancing microbial biotechnology and novel compound discovery.

“His comprehensive educational and professional training, involvement in peer review, and long record of pivotal findings firmly denote [Client] as an accomplished and impactful researcher in microbiology who has a degree of expertise and skill possessed by few others in the field.”

The experts underscored how his contributions are helping to shape modern antibiotic and enzyme development strategies, which are vital to addressing ongoing global health and industrial challenges.

A Strong Case for Continued Impact in U.S. Biotechnology

By demonstrating the petitioner’s proven record of research excellence, international recognition, and alignment with key U.S. scientific priorities, we successfully secured a National Interest Waiver approval. His ongoing work will continue to support American innovation in drug development and sustainable biotechnology. We are proud to support his future success.